Magee Thomson Investment Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Magee Thomson Investment Partners’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1K	Buy	+299	New	+$577	﹤0.01%	94

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Magee Thomson Investment Partners's BDSI Position: Q1 2017 in Review

Magee Thomson Investment Partners opened a new position in BioDelivery Sciences International, Inc. (BDSI) in Q1 2017: 299 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #94 among its holdings.

63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

Magee Thomson Investment Partners held 299 shares of BioDelivery Sciences International, Inc. worth $1K as of Q1 2017.
BioDelivery Sciences International, Inc. was a new Magee Thomson Investment Partners position in Q1 2017.
BioDelivery Sciences International, Inc. made up ﹤0.01% of Magee Thomson Investment Partners's portfolio in Q1 2017, its #94 holding.
63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.